Enamel matrix derivative as adjunctive to non-surgical periodontal therapy: a systematic review and meta-analysis of randomized controlled trials

Abstract

Objectives To assess the potential additional benefit of the local application of enamel matrix derivative (EMD) on the clinical outcomes following non-surgical periodontal therapy (NSPT) (steps 1 and 2 periodontal therapy). Materials and Methods A systematic literature search was performed in several electronic databases, including Medline/PubMed, Embase, The Cochrane Register of Central Trials (CENTRAL), LILACS, and grey literature. Only randomized controlled clinical trials (RCTs) were eligible for inclusion. Clinical attachment level (CAL) change (primary outcome), probing pocket depth (PPD), and bleeding on probing (BoP) reductions (secondary outcomes) were evaluated. The Cochrane Risk of Bias tool (RoB 2.0) was used to assess the quality of the included trials. Weighted mean differences (WMDs) and 95% confidence intervals (CIs) between test and control sites were estimated using a random-effect model for amount of mean CAL and PPD change. Results Six RCTs were included for the qualitative analysis, while data from 4 studies were used for meta-analysis. Overall analysis of CAL gain (3 studies) and PPD reduction (4 studies) presented WMD of 0.14 mm (p = 0.74; CI 95% − 0.66; 0.94) and 0.46 mm (p = 0.25; CI 95% − 0.33; 1.26) in favor of NSPT + EMD compared to NSPT alone respectively. Statistical heterogeneity was found to be high in both cases (I2 = 79% and 87%, respectively). Conclusions Within their limitations, the present data indicate that the local application of EMD does not lead to additional clinical benefits after 3 to 12 months when used as an adjunctive to NSPT. However, due to the high heterogeneity among the studies, additional well-designed RCTs are needed to provide further evidence on this clinical indication for the use of EMD. Clinical relevance The adjunctive use of EMD to NSPT does not seem to additionally improve the clinical outcomes obtained with NSPT alone.

Effect of implant type on the stability of cantilever fixed dental prostheses: An in vitro study

“…The effect of implant design has not been the focus of previous clinical studies and reviews (Horsch et al, 2022;Kadkhodazadeh et al, 2023;Roccuzzo et al, 2023). In the present in vitro study, the outcome of ICFDPs on bone-level implants seemed to be more predictable, as the aging protocol did not affect the fracture load as severely as for tissue-level implants.…”

Fabrication of hydroxyapatite reinforced polymeric hydrogel membrane for regeneration

“…The tissues that support teeth are called periodontium, and they are made up of alveolar bone, cementum, gingiva, and periodontal ligament (PDL)( Xiong et al, 2013 ). An inflammatory condition called periodontitis causes the periodontal tissues to deteriorate, resulting in tooth mobility and finally tooth loss( Roccuzzo et al, 2022 ). Scaling and root planing, as well as surgical procedures, are now the main clinical therapies for periodontitis that target removing plaque and reducing local inflammation ( Duran-Pinedo et al, 2023 , Rajesh et al, 2011 ).…”

Enamel matrix derivative for alveolar ridge preservation: A randomized controlled trial

“…EMD is a protein derived from porcine tooth buds that has been widely used in regenerative periodontal and mucogingival therapy than any other biologics (Miron et al, 2016). EMD has shown successful results in the regeneration of recession and intrabony defects around natural teeth (Miron et al, 2016; Nibali et al, 2020; Roccuzzo et al, 2022) as well as in the management of peri‐implant mucosal recessions and bony defects (Esberg et al, 2019; Isehed et al, 2016; Kashefimehr et al, 2017). These benefits are related to the ability of EMD in inducing early vascularization and supporting early bone formation (Boyan et al, 2000).…”